OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...